BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37529638)

  • 1. Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD.
    Ronco R; Franco G; Monzio Compagnoni M; Aliberti S; Luppi F; Corrao G; Faverio P
    ERJ Open Res; 2023 Jul; 9(4):. PubMed ID: 37529638
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence and Healthcare Burden of Pertussis among Older Adults with and without Pre-Existing Chronic Obstructive Pulmonary Disease or Asthma in South Korea.
    Chen J; Shin JY; Kim H; Kim JH; Choi A; Cheong HJ; Oh YM; Guignard A; Shantakumar S
    COPD; 2023 Dec; 20(1):126-134. PubMed ID: 37093711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare costs with tiotropium plus usual care versus usual care alone following 1 year of treatment in patients with chronic obstructive pulmonary disorder (COPD).
    Friedman M; Menjoge SS; Anton SF; Kesten S
    Pharmacoeconomics; 2004; 22(11):741-9. PubMed ID: 15250751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the appropriateness of prescribing practice of inhaled pharmacotherapy among Aboriginal Australians in the Top End Northern Territory of Australia: a retrospective cohort study.
    Heraganahally S; Howarth TP; Issac S; Lloyd A; Ravichandran SJ; Abeyaratne A; Patel B
    BMJ Open Respir Res; 2023 Mar; 10(1):. PubMed ID: 36878611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes of Noninvasive Ventilation in Asthma, Bronchiectasis, and Other COPD.
    Nemeh C; Dongarwar D; Oduguwa E; Salihu HM; Barrantes Perez J
    South Med J; 2021 Dec; 114(12):766-771. PubMed ID: 34853852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis.
    Veith M; Tüffers J; Peychev E; Klemmer A; Kotke V; Janciauskiene S; Wilhelm S; Bals R; Koczulla AR; Vogelmeier CF; Greulich T
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2827-2836. PubMed ID: 33192056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution and Comparative Analysis of Hospitalizations in Spain Due to COPD and Bronchiectasis between 2004 and 2015.
    Navarro-Rolon A; Rosa-Carrillo D; Esquinas C; Miravitlles M; Martinez-García MA; Almagro P
    COPD; 2021 Apr; 18(2):210-218. PubMed ID: 33729066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-economic evaluation of home telemonitoring for COPD in Germany: evidence from a large population-based cohort.
    Achelrod D; Schreyögg J; Stargardt T
    Eur J Health Econ; 2017 Sep; 18(7):869-882. PubMed ID: 27699567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare utilisation and costs associated with adding montelukast to current therapy in patients with mild to moderate asthma and co-morbid allergic rhinitis: PRAACTICAL study.
    Dal Negro R; Piskorz P; Vives R; Guilera M; Sazonov Kocevar V; Badia X
    Pharmacoeconomics; 2007; 25(8):665-76. PubMed ID: 17640108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical activity associates with disease characteristics of severe asthma, bronchiectasis and COPD.
    Cordova-Rivera L; Gibson PG; Gardiner PA; McDonald VM
    Respirology; 2019 Apr; 24(4):352-360. PubMed ID: 30384396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Projections of future resource use and the costs of asthma and COPD in the Netherlands].
    Hoogendoorn M; Feenstra TL; Rutten-van Mölken MP
    Ned Tijdschr Geneeskd; 2006 Jun; 150(22):1243-50. PubMed ID: 16796176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficiency of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease, bronchiectasis, and asthma: Does it differ?
    Şahin ME; Satar S; Ergün P
    Turk J Med Sci; 2023 Jun; 53(3):814-823. PubMed ID: 37476889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suboptimal Peak Inspiratory Flow and Critical Inhalation Errors are Associated with Higher COPD-Related Healthcare Costs.
    Leving MT; van Boven JFM; Bosnic-Anticevich SZ; van Cooten J; Correia de Sousa J; Cvetkovski B; Dekhuijzen R; Dijk L; García Pardo M; Gardev A; Gawlik R; van der Ham I; Hartgers-Gubbels ES; Janse Y; Lavorini F; Maricoto T; Meijer J; Metz B; Price DB; Roman-Rodríguez M; Schuttel K; Stoker N; Tsiligianni I; Usmani OS; Kocks JH
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2401-2415. PubMed ID: 36185173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of nurse-led outpatient management of children with asthma on healthcare resource utilisation and costs.
    Kamps AW; Roorda RJ; Kimpen JL; Overgoor-van de Groes AW; van Helsdingen-Peek LC; Brand PL
    Eur Respir J; 2004 Feb; 23(2):304-9. PubMed ID: 14979508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients hospitalized with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics.
    Venning V; Bartlett J; Jayaram L
    Respirology; 2017 Jul; 22(5):922-927. PubMed ID: 28236369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Cross-Sectional Comparison of Direct Medical Care Costs among COPD and Asthma Patients Living in the Community in Northern Ireland.
    Murtagh E; O'neill C; McAllister D; Kee F; Macmahon J; Heaney LG
    Treat Respir Med; 2006; 5(6):495-501. PubMed ID: 17154676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of patients with non-cystic fibrosis bronchiectasis in Germany - A healthcare insurance claims data analysis.
    Diel R; Ewig S; Blaas S; Jacob C; Juelich F; Korfmann G; Sohrab S; Sutharsan S; Rademacher J
    Respir Med; 2019 May; 151():121-127. PubMed ID: 31047108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Societal costs of asthma, COPD and respiratory allergy].
    Suijkerbuijk AW; de Wit GA; Wijga AH; Heijmans M; Hoogendoorn M; Rutten-van Mölken M; Maurits EE; Hoogenveen RT; Feenstra TL
    Ned Tijdschr Geneeskd; 2013; 157(46):A6562. PubMed ID: 24220178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sedentary time in people with obstructive airway diseases.
    Cordova-Rivera L; Gardiner PA; Gibson PG; Winkler EAH; Urroz PD; McDonald VM
    Respir Med; 2021 May; 181():106367. PubMed ID: 33831731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with high healthcare resource utilisation among COPD patients.
    García-Polo C; Alcázar-Navarrete B; Ruiz-Iturriaga LA; Herrejón A; Ros-Lucas JA; García-Sidro P; Tirado-Conde G; López-Campos JL; Martínez-Rivera C; Costán-Galicia J; Mayoralas-Alises S; De Miguel-Díez J; Miravitlles M;
    Respir Med; 2012 Dec; 106(12):1734-42. PubMed ID: 23058483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.